These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-004904-19 A two-centre, open label study of weekly pegvisomant treatment for patients with acromegaly not-yet-due
Not reported 2004-005184-15 Central Hypothyroidism and Adjusted Thyroxine dose Study (CHATS): impact of increasing free thyroxine levels in patients with hypopituitarism 2011-03-23 due-trials
Ongoing 2005-002698-65 A randomised clinical trial comparing safety and efficacy of topical preparations for the eradication of methicillin resistant staphylococcus aureus (MRSA) compared with a novel preparation based on a... not-yet-due
Ongoing 2005-005660-86 A Phase II, open label, single arm study to evaluate Ticilimumab in Advanced Gastric/Oesophageal Adenocarcinoma not-yet-due
Ongoing 2006-000344-10 Multi-centre study of cabergoline alone and in combination with pegvisomant in the management of active acromegaly not-yet-due
Ongoing 2006-000598-31 Phase II Study of Fractionated 90Y Ibritumomab tiuxetan (ZevalinTM) as initial therapy of Follicular Lymphoma not-yet-due
Ongoing 2006-001742-13 Locally Advanced Pancreatic Cancer: Phase II study of cetuximab and 3-D conformal image-guided radiotherapy (PACER Study) not-yet-due
Not reported 2006-004989-14 The Effect of Raloxifene on Serum IGF-I in Patients with Acromegaly on long-term Octeotide Treatment 2010-11-01 due-trials
Not reported 2006-005566-39 Concurrent chemoradiotherapy for stage III non small cell lung cancer followed by consolidation pemetrexed: a phase II study 2010-10-21 due-trials
Ongoing 2007-000741-36 Study of radiotherapy dose escalation with Intensity Modulated Radiation Therapy (IMRT) and synchronous Cetuximab for intermediate stage head and neck cancer not-yet-due
Ongoing 2007-002053-24 A phase II study evaluating the use of concurrent cetuximab, irinotecan, oxaliplatin and UFT in the first line treatment of patients with metastatic colorectal cancer not-yet-due
Ongoing 2007-004749-14 Assessing the Feasibility of a Single Blind Randomised Controlled Trial to Measure the Effectiveness of D-Alpha-Tocopherol in the Management of Oral Mucositis in Patients Undergoing Conditioning for B... not-yet-due
Reported results 2007-005242-21 A pilot study of replacement therapy with recombinant TSH in central hypothyroidism 2011-04-08 due-trials
Ongoing 2008-000066-22 A Phase 2 study of Sorafenib (BAY 43-9006) in patients with advanced salivary Adenoid Cystic Carcinoma not-yet-due
Ongoing 2008-002686-30 Assessment of the effects of the specific endothelin-A antagonist ZD4054 on prostate cancer biomarkers in patients with castrate-resistant metastatic disease not-yet-due
Ongoing 2009-011078-14 A single arm phase II study to investigate the use of Lenalidomide in the treatment of patients with early stage CLL associated with poor prognostic factors. not-yet-due
Ongoing 2012-005327-33 A Phase II Trial to Assess the Activity of NY-ESO-1 Targeted T Cells in Advanced Oesophagogastric Cancer not-yet-due
Not reported 2013-000139-28 A single arm double-blind placebo controlled cross-over trial of Aprepitant for the treatment of cough in lung cancer: “CALC” Trial 2014-11-17 due-trials
Not reported Terminated 2013-001071-20 A Randomised Phase II Study in Metastatic Melanoma to Evaluate the Efficacy of Adoptive Cellular Therapy with Tumour Infiltrating Lymphocytes (TIL) and Assessment of High versus Low Dose Interleukin-2 2015-09-15 due-trials
Ongoing 2013-001812-30 A Phase III, randomised, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin/5-FU chemotherapy for patients with locally advanced/metastatic biliary tract canc... not-yet-due
Ongoing 2013-002073-22 A Phase II Trial of PLX3397 in the Treatment of KIT Mutated Advanced Acral and Mucosal Melanoma( PIANO) not-yet-due
Ongoing 2013-002466-39 A randomised placebo-controlled trial of synchronous NIMorazole versus RADiotherapy alone in patients with locally advanced head and neck squamous cell carcinoma not suitable for synchronous chemother... not-yet-due
Exempt 2013-005471-40 PAZOFOS: A Phase Ib and Randomised Phase II Trial of Pazopanib with or without Fosbretabulin in Advanced Recurrent Ovarian Cancer not-yet-due
Ongoing 2015-003883-36 Single arm feasibility of multi-maintenance olaparib after disease recurrence in participants with platinum sensitive BRCAm high grade serous ovarian cancer not-yet-due